Dept. of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Campus A4 1, D-66123 Saarbrücken, Germany; Department of Pharmaceutics, Alexandria University, Alexandria 21521, Egypt.
Dept. of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Campus A4 1, D-66123 Saarbrücken, Germany.
J Control Release. 2015 Dec 28;220(Pt A):414-424. doi: 10.1016/j.jconrel.2015.10.052. Epub 2015 Oct 29.
Intracellular bacteria invade mammalian cells to establish an infectious niche. The current work models adhesion and subsequent internalization strategy of pathogenic bacteria into mammalian cells to design a bacteriomimetic bioinvasive delivery system. We report on the surface functionalization of liposomes with a C-terminal fragment of invasin (InvA497), an invasion factor in the outer membrane of Yersinia pseudotuberculosis. InvA497-functionalized liposomes adhere to mammalian epithelial HEp-2 cell line at different infection stages with a significantly higher efficiency than liposomes functionalized with bovine serum albumin. Covalent attachment of InvA497 results in higher cellular adhesion than liposomes with physically adsorbed InvA497 with non-specific surface protein alignment. Uptake studies in HEp-2 cells indicate active internalization of InvA497-functionalized liposomes via β1-integrin receptor-mediated uptake mechanism mimicking the natural invasion strategy of Y. pseudotuberculosis. Uptake studies in Caco-2 cells at different polarization states demonstrate specific targeting of the InvA497-functionalized liposomes to less polarized cells reflecting the status of inflamed cells. Moreover, when loaded with the anti-infective agent gentamicin and applied to HEp-2 cells infected with Y. pseudotuberculosis, InvA497-functionalized liposomes are able to significantly reduce the infection load relative to non-functionalized drug-loaded liposomes. This indicates a promising application of such a bacteriomimetic system for drug delivery to intracellular compartments.
细胞内细菌侵入哺乳动物细胞以建立感染小生境。目前的工作模拟了致病性细菌黏附和随后内化进入哺乳动物细胞的策略,以设计一种细菌模拟的生物入侵递药系统。我们报告了用假结核耶尔森菌外膜中侵袭因子(InvA497)的 C 末端片段对脂质体进行表面功能化。与用牛血清白蛋白功能化的脂质体相比,InvA497 功能化的脂质体在不同的感染阶段黏附到哺乳动物上皮细胞系 HEp-2 的效率显著更高。InvA497 的共价附着导致比具有非特异性表面蛋白排列的物理吸附 InvA497 的脂质体更高的细胞黏附。在 HEp-2 细胞中的摄取研究表明,InvA497 功能化的脂质体通过β1-整联蛋白受体介导的摄取机制被主动内化,模拟了假结核耶尔森菌的天然入侵策略。在不同极化状态的 Caco-2 细胞中的摄取研究表明,InvA497 功能化的脂质体特异性靶向极化程度较低的细胞,反映了炎症细胞的状态。此外,当用抗感染剂庆大霉素负载并应用于感染假结核耶尔森菌的 HEp-2 细胞时,与未功能化的载药脂质体相比,InvA497 功能化的脂质体能够显著降低感染负荷。这表明这种细菌模拟系统在向细胞内隔室递药方面有很大的应用潜力。